Advertisement
Screener

RadNet, Inc. (RDNT) Cash and Cash Equivalents, Period Increase (Decrease)

2.5 / 5 stars · 46/92 Roast Me

RadNet, Inc. Cash and Cash Equivalents, Period Increase (Decrease)

RadNet, Inc. (RDNT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $29.78 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-03-16

  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $2.48M.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $7.18M, a 34.54% decline year-over-year.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $20.08M.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $39.00K.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $29.78M.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$40.93M, a 233.40% decline from fiscal 2017.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $30.68M, a 51.96% increase from fiscal 2016.
  • RadNet, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $20.19M, a 14426.62% increase from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2019-12-31$2.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$9.66M
derived: sum of 2 quarters · filed 2020-03-16
$29.74M
derived: sum of 3 quarters · filed 2020-03-16
$29.78M
10-K · filed 2020-03-16
2019-09-30$7.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$27.26M
derived: sum of 2 quarters · filed 2019-11-12
$27.30M
10-Q · filed 2019-11-12
$10.46M
derived: sum of 4 quarters · filed 2020-03-16
2019-06-30$20.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$20.11M
10-Q · filed 2019-08-09
$3.28M
derived: sum of 3 quarters · filed 2020-03-16
$14.25M
derived: sum of 4 quarters · filed 2020-03-16
2019-03-31$39.00K
10-Q · filed 2019-05-10
-$16.80M
derived: sum of 2 quarters · filed 2020-03-16
-$5.82M
derived: sum of 3 quarters · filed 2020-03-16
-$24.61M
derived: sum of 4 quarters · filed 2020-03-16
2018-12-31-$16.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$5.86M
derived: sum of 2 quarters · filed 2020-03-16
-$24.65M
derived: sum of 3 quarters · filed 2020-03-16
-$40.93M
10-K · filed 2020-03-16
2018-09-30$10.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$7.82M
derived: sum of 2 quarters · filed 2019-11-12
-$24.09M
10-Q · filed 2019-11-12
$18.76M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$18.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$35.07M
10-Q · filed 2019-08-09
$7.78M
derived: sum of 3 quarters · filed 2020-03-16
$3.54M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$16.28M
10-Q · filed 2019-05-10
$26.57M
derived: sum of 2 quarters · filed 2020-03-16
$22.34M
derived: sum of 3 quarters · filed 2020-03-16
$26.75M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$42.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$38.62M
derived: sum of 2 quarters · filed 2020-03-16
$43.03M
derived: sum of 3 quarters · filed 2020-03-16
$30.68M
10-K · filed 2020-03-16
2017-09-30-$4.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$174.00K
derived: sum of 2 quarters · filed 2018-11-09
-$12.17M
10-Q · filed 2018-11-09
$8.11M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$4.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$7.93M
10-Q · filed 2018-08-09
$12.35M
derived: sum of 3 quarters · filed 2019-03-18
$12.27M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$12.34M
10-Q · filed 2018-05-10
$7.94M
derived: sum of 2 quarters · filed 2019-03-18
$7.86M
derived: sum of 3 quarters · filed 2019-03-18
$7.88M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$20.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$20.20M
derived: sum of 2 quarters · filed 2019-03-18
$20.23M
derived: sum of 3 quarters · filed 2019-03-18
$20.19M
10-K · filed 2019-03-18
2016-09-30-$75.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$52.00K
derived: sum of 2 quarters · filed 2017-11-09
-$88.00K
10-Q · filed 2017-11-09
-$35.70M
derived: sum of 4 quarters · filed 2018-03-19
2016-06-30$23.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$13.00K
10-Q · filed 2017-08-09
-$35.62M
derived: sum of 3 quarters · filed 2018-03-19
-$4.89M
derived: sum of 4 quarters · filed 2018-03-19
2016-03-31-$36.00K
10-Q · filed 2017-05-10
-$35.64M
derived: sum of 2 quarters · filed 2018-03-19
-$4.91M
derived: sum of 3 quarters · filed 2018-03-19
$256.00K
derived: sum of 4 quarters · filed 2018-03-19
2015-12-31-$35.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
-$4.87M
derived: sum of 2 quarters · filed 2018-03-19
$292.00K
derived: sum of 3 quarters · filed 2018-03-19
$139.00K
10-K · filed 2018-03-19
2015-09-30$30.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$35.90M
derived: sum of 2 quarters · filed 2016-11-09
$35.75M
10-Q · filed 2016-11-09
$43.60M
derived: sum of 4 quarters · filed 2017-03-31
2015-06-30$5.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$5.01M
10-Q · filed 2016-08-09
$12.87M
derived: sum of 3 quarters · filed 2017-03-31
$12.31M
derived: sum of 4 quarters · filed 2017-03-31
2015-03-31-$153.00K
10-Q · filed 2016-05-10
$7.70M
derived: sum of 2 quarters · filed 2017-03-31
$7.14M
derived: sum of 3 quarters · filed 2017-03-31
$7.68M
derived: sum of 4 quarters · filed 2017-03-31
2014-12-31$7.85M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-31
$7.30M
derived: sum of 2 quarters · filed 2017-03-31
$7.84M
derived: sum of 3 quarters · filed 2017-03-31
-$285.00K
10-K/A · filed 2017-03-31
-$8.11M
10-K · filed 2015-03-16
2014-09-30-$557.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$17.00K
derived: sum of 2 quarters · filed 2015-11-09
-$8.14M
10-Q · filed 2015-11-09
-$9.53M
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30$540.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$7.58M
10-Q · filed 2015-08-10
-$8.98M
derived: sum of 3 quarters · filed 2016-03-30
-$8.96M
derived: sum of 4 quarters · filed 2016-03-30
2014-03-31-$8.12M
10-Q · filed 2015-05-11
-$9.52M
derived: sum of 2 quarters · filed 2016-03-30
-$9.50M
derived: sum of 3 quarters · filed 2016-03-30
-$9.68M
derived: sum of 4 quarters · filed 2016-03-30
2013-12-31-$1.40M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-03-30
-$1.38M
derived: sum of 2 quarters · filed 2016-03-30
-$1.56M
derived: sum of 3 quarters · filed 2016-03-30
-$1.49M
10-K/A · filed 2016-03-30
$8.05M
10-K · filed 2014-03-17
2013-09-30$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$163.00K
derived: sum of 2 quarters · filed 2014-11-10
-$94.00K
10-Q · filed 2014-11-10
$1.66M
derived: sum of 4 quarters · filed 2015-03-31
2013-06-30-$180.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$111.00K
10-Q · filed 2014-08-11
$1.65M
derived: sum of 3 quarters · filed 2015-03-31
$1.80M
derived: sum of 4 quarters · filed 2015-03-31
2013-03-31$69.00K
10-Q · filed 2014-05-12
$1.82M
derived: sum of 2 quarters · filed 2015-03-31
$1.98M
derived: sum of 3 quarters · filed 2015-03-31
$379.00K
derived: sum of 4 quarters · filed 2015-03-31
2012-12-31$1.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$1.91M
derived: sum of 2 quarters · filed 2015-03-31
$310.00K
derived: sum of 3 quarters · filed 2015-03-31
-$311.00K
10-K · filed 2015-03-31
-$2.09M
10-K · filed 2013-03-18
2012-09-30$154.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$1.45M
derived: sum of 2 quarters · filed 2013-11-13
-$2.07M
10-Q · filed 2013-11-13
-$1.41M
derived: sum of 4 quarters · filed 2014-03-31
2012-06-30-$1.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
-$2.22M
10-Q · filed 2013-08-09
-$1.57M
derived: sum of 3 quarters · filed 2014-03-31
-$1.49M
derived: sum of 4 quarters · filed 2014-03-31
2012-03-31-$621.00K
10-Q · filed 2013-05-10
$33.00K
derived: sum of 2 quarters · filed 2014-03-31
$109.00K
derived: sum of 3 quarters · filed 2014-03-31
$28.00K
derived: sum of 4 quarters · filed 2014-03-31
2011-12-31$654.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-31
$730.00K
derived: sum of 2 quarters · filed 2014-03-31
$649.00K
derived: sum of 3 quarters · filed 2014-03-31
$281.00K
10-K/A · filed 2014-03-31
$1.83M
10-K · filed 2012-03-13
2011-09-30$76.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-09
-$5.00K
derived: sum of 2 quarters · filed 2012-11-09
-$373.00K
10-Q · filed 2012-11-09
-$14.39M
derived: sum of 4 quarters · filed 2013-11-13
2011-06-30-$81.00K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30
-$449.00K
10-Q/A · filed 2012-08-30
-$14.46M
derived: sum of 3 quarters · filed 2013-11-13
-$10.48M
derived: sum of 4 quarters · filed 2013-11-13
2011-03-31-$368.00K
10-Q · filed 2012-05-10
-$14.38M
derived: sum of 2 quarters · filed 2013-11-13
-$10.40M
derived: sum of 3 quarters · filed 2013-11-13
2010-12-31-$14.02M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-13
-$10.03M
derived: sum of 2 quarters · filed 2013-11-13
$352.00K
10-K/A · filed 2013-11-13
-$9.47M
10-K · filed 2012-03-13
2010-09-30$3.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$14.37M
10-Q · filed 2011-11-09
2010-06-30$10.38M
10-Q · filed 2011-08-09
2009-12-31$10.09M
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70